Morgan Stanley (MS)

The efficacy of Eli Lilly's new, still-in-development GLP-1 drug is gaining attention, but don't forget its older GLP-1 drugs just yet.

As Paychex has underperformed relative to the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

While CMS Energy has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Despite Expand Energy’s underperformance compared to the broader market over the past year, Wall Street analysts remain very bullish in the company’s long-term growth trajectory.

Although Raymond James has lagged the broader market over the past year, Wall Street analysts remain moderately optimistic about the company’s long-term outlook.

F5 has outpaced the S&P 500 Index over the past year, and analysts are fairly bullish on its future outlook.

SpaceX’s historic IPO is drawing huge retail interest, but history shows mega IPOs often stumble after launch-day excitement fades. Valuation and hype may outweigh opportunity for now.

Synopsys has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Although Northern Trust has exceeded the broader market over the past 52 weeks, Wall Street analysts remain cautious about the stock's prospects.

DRAM prices are rising fast on tight supply and AI demand, giving Micron a strong pricing tailwind through 2027.

Atlassian and Datadog both surged more than 30% after strong Q1 2026 earnings, suggesting AI is a tailwind for some software stocks rather than a threat.

Wall Street is watching May 22 closely as OpenAI reportedly prepares for a potentially confidential IPO filing.

Mid-America Apartment has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Tesla's Chinese rival Li Auto (LI) remains underpriced as its value score rises. Morgan Stanley sees 61% upside potential.

These companies are spearheading the trillion-dollar space economy.

The Sage Group (LON:SGE) reported what Chief Executive Officer Steve Hare called an “excellent first half” of fiscal 2026, citing broad-based double-digit revenue growth, margin expansion and accelerating annualized recurring revenue as the business continued to invest in artificial intelligence acr

It all comes down to whether you trust management to deliver its long-term turnaround plan.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...

Goldman Sachs won a PR coup today -- and a bit of money, too.

What Happened? Shares of semiconductor machinery manufacturer Applied Materials (NASDAQ:AMAT) jumped 4.9% in the afternoon session after the company announce...

Morgan Stanley has upgraded Lam Research to Overweight rating following a wafer fabrication equipment industry raise.

An OpenAI IPO filing could come later this week as the ChatGPT parent works with bankers, according to a new report.

Discover why Cipher Mining Inc. (NASDAQ:CIFR) stock is surging on Wednesday as Morgan Stanley raises its price target amid a massive AI data center pivot.

Wall Street analysts changed outlook on top names. Goldman Sachs raised PSX target, BTIG cut DRVN target, Morgan Stanley cut NWL target, B of A raised TK target, Stifel raised PANW target, Mizuho cut HD target, Goldman Sachs raised ENPH target, B of A raised NTAP target.

Goldman Sachs selected as lead left underwriter for SpaceX's upcoming IPO, with Morgan Stanley also leading.